This hypercoagulable state is attributed to high expression of tissue factor (TF) and transmembrane proteins (e.g.: PSGL-1, Muc1) by cancer cells [50], leading to thrombin generation and platelet activation and aggregation [51]. The gene discussed is TF; the disease is cancer.